Industry Research Reports

Home > Reports > Service & Software > Global Spatial Transcriptomics Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Spatial Transcriptomics Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-07-18

Pages: 116 Pages

Report ld: 6977907

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spatial Transcriptomics Platform Market Size(US$)

CAGR 2026-2032

14.6%

Market Size,2032

USD 1,185

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 523 million

Market Forecast in 2032(Value)

US$ 1,185 million

CAGR

14.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Spatial Transcriptomics Platform market size was US$ 455 million in 2025 and is forecast to reach a readjusted size of US$ 1185 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.

Spatial transcriptomics platforms combine instruments, reagents and consumables, library-preparation workflows, and software to localize and quantify RNA expression in tissue sections while preserving morphology and spatial coordinates. They mainly use spatial barcoding and sequencing, in situ hybridization imaging, in situ sequencing, or region-of-interest digital profiling, and can provide whole-transcriptome or targeted gene measurements integrated with pathology images, cell segmentation, and protein-marker data. Key purchasing parameters include spatial resolution, transcript coverage, sensitivity, capture area, sample compatibility, throughput per run, automation, and data-analysis capability. Primary users include research institutions, core facilities, biopharmaceutical companies, and translational medicine centers. The blended gross margin is approximately 60%.

Research on tumor microenvironments, brain-region cell atlases, embryonic development, immune inflammation, and drug mechanisms requires gene-expression measurements linked to tissue location. This is moving spatial transcriptomics from small validation experiments toward larger, standardized projects. Growing interest in archived pathology samples and the need for spatial evidence in target discovery, patient stratification, and pharmacodynamic assessment are increasing demand for FFPE-compatible, high-throughput, and reproducible workflows.

Competition centers on spatial resolution, gene plex, transcript-detection sensitivity, effective imaging or capture area, sample compatibility, run time, and cost per sample. Sequencing-based platforms are strongest in whole-transcriptome discovery, while imaging-based platforms emphasize single-cell and subcellular localization. Leading suppliers are integrating instruments, reagents, panel design, image processing, cell segmentation, and cloud analytics into closed workflows. Development priorities include larger tissue areas, higher gene throughput, same-section RNA and protein detection, automated sample handling, and cross-platform data standardization.

North America and Europe continue to concentrate major core facilities, pharmaceutical customers, and premium instrument installations, while China and the wider Asia-Pacific region are expanding through local spatial-omics technologies, sequencing infrastructure, and translational research investment. Opportunities include oncology translational studies, neuroscience, tissue-atlas programs, drug-response databases, and clinical sample cohorts. Key risks include sample-preparation variation, batch effects, data and computing costs, inconsistent analytical algorithms, platform lock-in, and volatility in research budgets.

The global Spatial Transcriptomics Platform market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

10x Genomics
Bruker
Vizgen
STOmics
Curio Bioscience
Resolve Biosciences
Bio-Techne
Miltenyi Biotec
SeekGene
BMKMANU
CapitalBio Technology
Dynamic Biosystems
M20 Genomics
Singleron Biotechnologies
AtlasXomics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Sequencing-Based Spatial Barcoding Platforms
Imaging-Based in Situ Hybridization Platforms
In Situ Sequencing Platforms
Region-of-Interest Digital Profiling Platforms
Spatial Single-Nucleus Sequencing Platforms
Other or Hybrid Platforms

Segment by Application

Oncology Research
Neuroscience Research
Developmental and Regenerative Biology
Immunology and Infectious Disease
Organ Physiology and Metabolic Disease
Other Life Science Research

Segment by Category

Region-Level Resolution (>100 μm)
Spot-Level Resolution (20–100 μm)
Near-Cellular Resolution (5–<20 μm)
Single-Cell Resolution (1–<5 μm)
Subcellular Resolution (<1 μm)

Segment by Division

Whole-Transcriptome Profiling
Large Targeted Panels (≥1,000 Genes)
Medium Targeted Panels (100–999 Genes)
Small Targeted Panels (<100 Genes)

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Spatial Transcriptomics Platform value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Sequencing-Based Spatial Barcoding Platforms

1.2.3 Imaging-Based in Situ Hybridization Platforms

1.2.4 In Situ Sequencing Platforms

1.2.5 Region-of-Interest Digital Profiling Platforms

1.2.6 Spatial Single-Nucleus Sequencing Platforms

1.2.7 Other or Hybrid Platforms

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Oncology Research

1.3.3 Neuroscience Research

1.3.4 Developmental and Regenerative Biology

1.3.5 Immunology and Infectious Disease

1.3.6 Organ Physiology and Metabolic Disease

1.3.7 Other Life Science Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Spatial Transcriptomics Platform Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Spatial Transcriptomics Platform Market Share by Revenue, by Region (2021-2026)

2.4 Global Spatial Transcriptomics Platform Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.2 Europe Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.3 China Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.4 Japan Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.5 Southeast Asia Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.6 India Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.7 South America Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

2.5.8 Middle East Spatial Transcriptomics Platform Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Spatial Transcriptomics Platform Historical Market Size by Type (2021-2026)

3.2 Global Spatial Transcriptomics Platform Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Spatial Transcriptomics Platform

4 Breakdown Data by Application

4.1 Global Spatial Transcriptomics Platform Historical Market Size by Application (2021-2026)

4.2 Global Spatial Transcriptomics Platform Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Spatial Transcriptomics Platform Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Spatial Transcriptomics Platform Players by Revenue (2021-2026)

5.1.2 Global Spatial Transcriptomics Platform Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Spatial Transcriptomics Platform Revenue

5.4 Global Spatial Transcriptomics Platform Market Concentration Analysis

5.4.1 Global Spatial Transcriptomics Platform Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Spatial Transcriptomics Platform Revenue in 2025

5.5 Global Key Players of Spatial Transcriptomics Platform Head Offices and Areas Served

5.6 Global Key Players of Spatial Transcriptomics Platform, Product and Application

5.7 Global Key Players of Spatial Transcriptomics Platform, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Spatial Transcriptomics Platform Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Spatial Transcriptomics Platform Market Size by Type (2021-2026)

6.1.2.2 North America Spatial Transcriptomics Platform Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Spatial Transcriptomics Platform Market Size by Application (2021-2026)

6.1.3.2 North America Spatial Transcriptomics Platform Market Share by Application (2021-2026)

6.1.4 North America Spatial Transcriptomics Platform Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Spatial Transcriptomics Platform Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Spatial Transcriptomics Platform Market Size by Type (2021-2026)

6.2.2.2 Europe Spatial Transcriptomics Platform Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Spatial Transcriptomics Platform Market Size by Application (2021-2026)

6.2.3.2 Europe Spatial Transcriptomics Platform Market Share by Application (2021-2026)

6.2.4 Europe Spatial Transcriptomics Platform Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Spatial Transcriptomics Platform Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Spatial Transcriptomics Platform Market Size by Type (2021-2026)

6.3.2.2 China Spatial Transcriptomics Platform Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Spatial Transcriptomics Platform Market Size by Application (2021-2026)

6.3.3.2 China Spatial Transcriptomics Platform Market Share by Application (2021-2026)

6.3.4 China Spatial Transcriptomics Platform Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Spatial Transcriptomics Platform Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Spatial Transcriptomics Platform Market Size by Type (2021-2026)

6.4.2.2 Japan Spatial Transcriptomics Platform Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Spatial Transcriptomics Platform Market Size by Application (2021-2026)

6.4.3.2 Japan Spatial Transcriptomics Platform Market Share by Application (2021-2026)

6.4.4 Japan Spatial Transcriptomics Platform Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Asia Spatial Transcriptomics Platform Revenue by Company (2021-2026)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Spatial Transcriptomics Platform Market Size by Type (2021-2026)

6.5.2.2 Southeast Asia Spatial Transcriptomics Platform Market Share by Type (2021-2026)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Spatial Transcriptomics Platform Market Size by Application (2021-2026)

6.5.3.2 Southeast Asia Spatial Transcriptomics Platform Market Share by Application (2021-2026)

6.5.4 Southeast Asia Spatial Transcriptomics Platform Major Customers

6.5.5 Southeast Asia Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India Spatial Transcriptomics Platform Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India Spatial Transcriptomics Platform Market Size by Type (2021-2026)

6.6.2.2 India Spatial Transcriptomics Platform Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India Spatial Transcriptomics Platform Market Size by Application (2021-2026)

6.6.3.2 India Spatial Transcriptomics Platform Market Share by Application (2021-2026)

6.6.4 India Spatial Transcriptomics Platform Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 10x Genomics

7.1.1 10x Genomics Company Details

7.1.2 10x Genomics Business Overview

7.1.3 10x Genomics Spatial Transcriptomics Platform Introduction

7.1.4 10x Genomics Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.1.5 10x Genomics Recent Development

7.2 Bruker

7.2.1 Bruker Company Details

7.2.2 Bruker Business Overview

7.2.3 Bruker Spatial Transcriptomics Platform Introduction

7.2.4 Bruker Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.2.5 Bruker Recent Development

7.3 Vizgen

7.3.1 Vizgen Company Details

7.3.2 Vizgen Business Overview

7.3.3 Vizgen Spatial Transcriptomics Platform Introduction

7.3.4 Vizgen Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.3.5 Vizgen Recent Development

7.4 STOmics

7.4.1 STOmics Company Details

7.4.2 STOmics Business Overview

7.4.3 STOmics Spatial Transcriptomics Platform Introduction

7.4.4 STOmics Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.4.5 STOmics Recent Development

7.5 Curio Bioscience

7.5.1 Curio Bioscience Company Details

7.5.2 Curio Bioscience Business Overview

7.5.3 Curio Bioscience Spatial Transcriptomics Platform Introduction

7.5.4 Curio Bioscience Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.5.5 Curio Bioscience Recent Development

7.6 Resolve Biosciences

7.6.1 Resolve Biosciences Company Details

7.6.2 Resolve Biosciences Business Overview

7.6.3 Resolve Biosciences Spatial Transcriptomics Platform Introduction

7.6.4 Resolve Biosciences Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.6.5 Resolve Biosciences Recent Development

7.7 Bio-Techne

7.7.1 Bio-Techne Company Details

7.7.2 Bio-Techne Business Overview

7.7.3 Bio-Techne Spatial Transcriptomics Platform Introduction

7.7.4 Bio-Techne Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.7.5 Bio-Techne Recent Development

7.8 Miltenyi Biotec

7.8.1 Miltenyi Biotec Company Details

7.8.2 Miltenyi Biotec Business Overview

7.8.3 Miltenyi Biotec Spatial Transcriptomics Platform Introduction

7.8.4 Miltenyi Biotec Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.8.5 Miltenyi Biotec Recent Development

7.9 SeekGene

7.9.1 SeekGene Company Details

7.9.2 SeekGene Business Overview

7.9.3 SeekGene Spatial Transcriptomics Platform Introduction

7.9.4 SeekGene Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.9.5 SeekGene Recent Development

7.10 BMKMANU

7.10.1 BMKMANU Company Details

7.10.2 BMKMANU Business Overview

7.10.3 BMKMANU Spatial Transcriptomics Platform Introduction

7.10.4 BMKMANU Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.10.5 BMKMANU Recent Development

7.11 CapitalBio Technology

7.11.1 CapitalBio Technology Company Details

7.11.2 CapitalBio Technology Business Overview

7.11.3 CapitalBio Technology Spatial Transcriptomics Platform Introduction

7.11.4 CapitalBio Technology Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.11.5 CapitalBio Technology Recent Development

7.12 Dynamic Biosystems

7.12.1 Dynamic Biosystems Company Details

7.12.2 Dynamic Biosystems Business Overview

7.12.3 Dynamic Biosystems Spatial Transcriptomics Platform Introduction

7.12.4 Dynamic Biosystems Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.12.5 Dynamic Biosystems Recent Development

7.13 M20 Genomics

7.13.1 M20 Genomics Company Details

7.13.2 M20 Genomics Business Overview

7.13.3 M20 Genomics Spatial Transcriptomics Platform Introduction

7.13.4 M20 Genomics Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.13.5 M20 Genomics Recent Development

7.14 Singleron Biotechnologies

7.14.1 Singleron Biotechnologies Company Details

7.14.2 Singleron Biotechnologies Business Overview

7.14.3 Singleron Biotechnologies Spatial Transcriptomics Platform Introduction

7.14.4 Singleron Biotechnologies Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.14.5 Singleron Biotechnologies Recent Development

7.15 AtlasXomics

7.15.1 AtlasXomics Company Details

7.15.2 AtlasXomics Business Overview

7.15.3 AtlasXomics Spatial Transcriptomics Platform Introduction

7.15.4 AtlasXomics Revenue in Spatial Transcriptomics Platform Business (2021-2026)

7.15.5 AtlasXomics Recent Development

8 Spatial Transcriptomics Platform Market Dynamics

8.1 Spatial Transcriptomics Platform Industry Trends

8.2 Spatial Transcriptomics Platform Market Drivers

8.3 Spatial Transcriptomics Platform Market Challenges

8.4 Spatial Transcriptomics Platform Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Spatial Transcriptomics Platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Spatial Transcriptomics Platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Spatial Transcriptomics Platform Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Spatial Transcriptomics Platform Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Spatial Transcriptomics Platform Revenue Share by Region (2021-2026)

Table 6. Global Spatial Transcriptomics Platform Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Spatial Transcriptomics Platform Revenue Share Forecast by Region (2027-2032)

Table 8. Global Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Spatial Transcriptomics Platform Market Share by Revenue, by Type (2021-2026)

Table 10. Global Spatial Transcriptomics Platform Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Spatial Transcriptomics Platform Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Spatial Transcriptomics Platform Market Share by Revenue, by Application (2021-2026)

Table 15. Global Spatial Transcriptomics Platform Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Spatial Transcriptomics Platform Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Spatial Transcriptomics Platform Applications

Table 18. Global Spatial Transcriptomics Platform Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Spatial Transcriptomics Platform Market Share by Players (2021-2026)

Table 20. Global Top Spatial Transcriptomics Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spatial Transcriptomics Platform as of 2025)

Table 21. Ranking of Global Top Spatial Transcriptomics Platform Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Spatial Transcriptomics Platform Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Spatial Transcriptomics Platform, Headquarters and Area Served

Table 24. Global Key Players of Spatial Transcriptomics Platform, Product and Application

Table 25. Global Key Players of Spatial Transcriptomics Platform, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Spatial Transcriptomics Platform Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Spatial Transcriptomics Platform Market Share by Revenue, by Company (2021-2026)

Table 29. North America Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Spatial Transcriptomics Platform Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Spatial Transcriptomics Platform Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Spatial Transcriptomics Platform Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Spatial Transcriptomics Platform Market Share by Revenue, by Company (2021-2026)

Table 37. China Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Spatial Transcriptomics Platform Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Spatial Transcriptomics Platform Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Asia Spatial Transcriptomics Platform Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Asia Spatial Transcriptomics Platform Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Asia Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Asia Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 47. India Spatial Transcriptomics Platform Revenue by Company (2021-2026) & (US$ Million)

Table 48. India Spatial Transcriptomics Platform Market Share by Revenue, by Company (2021-2026)

Table 49. India Spatial Transcriptomics Platform Market Size by Type (2021-2026) & (US$ Million)

Table 50. India Spatial Transcriptomics Platform Market Size by Application (2021-2026) & (US$ Million)

Table 51. 10x Genomics Company Details

Table 52. 10x Genomics Business Overview

Table 53. 10x Genomics Spatial Transcriptomics Platform Product

Table 54. 10x Genomics Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 55. 10x Genomics Recent Development

Table 56. Bruker Company Details

Table 57. Bruker Business Overview

Table 58. Bruker Spatial Transcriptomics Platform Product

Table 59. Bruker Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 60. Bruker Recent Development

Table 61. Vizgen Company Details

Table 62. Vizgen Business Overview

Table 63. Vizgen Spatial Transcriptomics Platform Product

Table 64. Vizgen Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 65. Vizgen Recent Development

Table 66. STOmics Company Details

Table 67. STOmics Business Overview

Table 68. STOmics Spatial Transcriptomics Platform Product

Table 69. STOmics Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 70. STOmics Recent Development

Table 71. Curio Bioscience Company Details

Table 72. Curio Bioscience Business Overview

Table 73. Curio Bioscience Spatial Transcriptomics Platform Product

Table 74. Curio Bioscience Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 75. Curio Bioscience Recent Development

Table 76. Resolve Biosciences Company Details

Table 77. Resolve Biosciences Business Overview

Table 78. Resolve Biosciences Spatial Transcriptomics Platform Product

Table 79. Resolve Biosciences Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 80. Resolve Biosciences Recent Development

Table 81. Bio-Techne Company Details

Table 82. Bio-Techne Business Overview

Table 83. Bio-Techne Spatial Transcriptomics Platform Product

Table 84. Bio-Techne Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 85. Bio-Techne Recent Development

Table 86. Miltenyi Biotec Company Details

Table 87. Miltenyi Biotec Business Overview

Table 88. Miltenyi Biotec Spatial Transcriptomics Platform Product

Table 89. Miltenyi Biotec Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 90. Miltenyi Biotec Recent Development

Table 91. SeekGene Company Details

Table 92. SeekGene Business Overview

Table 93. SeekGene Spatial Transcriptomics Platform Product

Table 94. SeekGene Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 95. SeekGene Recent Development

Table 96. BMKMANU Company Details

Table 97. BMKMANU Business Overview

Table 98. BMKMANU Spatial Transcriptomics Platform Product

Table 99. BMKMANU Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 100. BMKMANU Recent Development

Table 101. CapitalBio Technology Company Details

Table 102. CapitalBio Technology Business Overview

Table 103. CapitalBio Technology Spatial Transcriptomics Platform Product

Table 104. CapitalBio Technology Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 105. CapitalBio Technology Recent Development

Table 106. Dynamic Biosystems Company Details

Table 107. Dynamic Biosystems Business Overview

Table 108. Dynamic Biosystems Spatial Transcriptomics Platform Product

Table 109. Dynamic Biosystems Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 110. Dynamic Biosystems Recent Development

Table 111. M20 Genomics Company Details

Table 112. M20 Genomics Business Overview

Table 113. M20 Genomics Spatial Transcriptomics Platform Product

Table 114. M20 Genomics Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 115. M20 Genomics Recent Development

Table 116. Singleron Biotechnologies Company Details

Table 117. Singleron Biotechnologies Business Overview

Table 118. Singleron Biotechnologies Spatial Transcriptomics Platform Product

Table 119. Singleron Biotechnologies Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 120. Singleron Biotechnologies Recent Development

Table 121. AtlasXomics Company Details

Table 122. AtlasXomics Business Overview

Table 123. AtlasXomics Spatial Transcriptomics Platform Product

Table 124. AtlasXomics Revenue in Spatial Transcriptomics Platform Business (2021-2026) & (US$ Million)

Table 125. AtlasXomics Recent Development

Table 126. Spatial Transcriptomics Platform Market Trends

Table 127. Spatial Transcriptomics Platform Market Drivers

Table 128. Spatial Transcriptomics Platform Market Challenges

Table 129. Spatial Transcriptomics Platform Market Restraints

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Spatial Transcriptomics Platform Product Picture

Figure 2. Global Spatial Transcriptomics Platform Market Share by Type: 2025 vs 2032

Figure 3. Sequencing-Based Spatial Barcoding Platforms Features

Figure 4. Imaging-Based in Situ Hybridization Platforms Features

Figure 5. In Situ Sequencing Platforms Features

Figure 6. Region-of-Interest Digital Profiling Platforms Features

Figure 7. Spatial Single-Nucleus Sequencing Platforms Features

Figure 8. Other or Hybrid Platforms Features

Figure 9. Global Spatial Transcriptomics Platform Market Share by Application: 2025 vs 2032

Figure 10. Oncology Research

Figure 11. Neuroscience Research

Figure 12. Developmental and Regenerative Biology

Figure 13. Immunology and Infectious Disease

Figure 14. Organ Physiology and Metabolic Disease

Figure 15. Other Life Science Research

Figure 16. Spatial Transcriptomics Platform Report Years Considered

Figure 17. Global Spatial Transcriptomics Platform Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 18. Global Spatial Transcriptomics Platform Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Spatial Transcriptomics Platform Market Share by Revenue, by Region: 2021 vs 2025

Figure 20. North America Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. Europe Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. China Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 23. Japan Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 24. Southeast Asia Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 25. India Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 26. South America Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 27. Middle East Spatial Transcriptomics Platform Revenue (US$ Million) Growth Rate (2021-2032)

Figure 28. Global Spatial Transcriptomics Platform Market Share by Players in 2025

Figure 29. Global Top Spatial Transcriptomics Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spatial Transcriptomics Platform as of 2025)

Figure 30. The Top 10 and 5 Players Market Share by Spatial Transcriptomics Platform Revenue in 2025

Figure 31. North America Spatial Transcriptomics Platform Market Share by Type (2021-2026)

Figure 32. North America Spatial Transcriptomics Platform Market Share by Application (2021-2026)

Figure 33. Europe Spatial Transcriptomics Platform Market Share by Type (2021-2026)

Figure 34. Europe Spatial Transcriptomics Platform Market Share by Application (2021-2026)

Figure 35. China Spatial Transcriptomics Platform Market Share by Type (2021-2026)

Figure 36. China Spatial Transcriptomics Platform Market Share by Application (2021-2026)

Figure 37. Japan Spatial Transcriptomics Platform Market Share by Type (2021-2026)

Figure 38. Japan Spatial Transcriptomics Platform Market Share by Application (2021-2026)

Figure 39. Southeast Asia Spatial Transcriptomics Platform Market Share by Type (2021-2026)

Figure 40. Southeast Asia Spatial Transcriptomics Platform Market Share by Application (2021-2026)

Figure 41. India Spatial Transcriptomics Platform Market Share by Type (2021-2026)

Figure 42. India Spatial Transcriptomics Platform Market Share by Application (2021-2026)

Figure 43. 10x Genomics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 44. Bruker Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 45. Vizgen Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 46. STOmics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 47. Curio Bioscience Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 48. Resolve Biosciences Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 49. Bio-Techne Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 50. Miltenyi Biotec Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 51. SeekGene Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 52. BMKMANU Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 53. CapitalBio Technology Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 54. Dynamic Biosystems Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 55. M20 Genomics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 56. Singleron Biotechnologies Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 57. AtlasXomics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021-2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 14.6% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Spatial Transcriptomics Platform in 2026? shouQi

What is the annual compound growth rate of the global Spatial Transcriptomics Platform market size from 2026 to 2032? shouQi

Which companies rank high in the global Spatial Transcriptomics Platform market? shouQi

What was the global market size of Spatial Transcriptomics Platform in 2032? shouQi

Related Reports

Spatial Transcriptomics Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spatial Transcriptomics Platform was estimated to be worth US$ 455 million in 2025 and is projected to reach US$ 1185 million, growing at a CAGR of 14.6% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 115
USD 3950.00
(Single User License)
Global Spatial Transcriptomics Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Transcriptomics Platform market is projected to grow from US$ 455 million in 2025 to US$ 1185 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 141
USD 4900.00
(Single User License)
Global Spatial Transcriptomics Platform Market Research Report 2026
The global Spatial Transcriptomics Platform market was valued at US$ 455 million in 2025 and is anticipated to reach US$ 1185 million by 2032, at a CAGR of 14.6% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 113
USD 2900.00
(Single User License)

Spatial Transcriptomics Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spatial Transcriptomics Platform was estimated to be worth US$ 455 million in 2025 and is projected to reach US$ 1185 million, growing at a CAGR of 14.6% from 2026 to 2032.
Published: 2026-07-18
Pages: 115
USD 3950.00 (Single User License)
Global Spatial Transcriptomics Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Transcriptomics Platform market is projected to grow from US$ 455 million in 2025 to US$ 1185 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 141
USD 4900.00 (Single User License)
Global Spatial Transcriptomics Platform Market Research Report 2026
The global Spatial Transcriptomics Platform market was valued at US$ 455 million in 2025 and is anticipated to reach US$ 1185 million by 2032, at a CAGR of 14.6% from 2026 to 2032.
Published: 2026-07-18
Pages: 113
USD 2900.00 (Single User License)